Talimogene laherparepvec (T-VEC)
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for Talimogene laherparepvec (T-VEC), covering 2015-12-18 to 2026-04-13. Get the full timeline:
Most recent: Clinical Trial Update: Talimogene Laherparepvec and Radiation Therapy in Treating Patients With Newly Diagnosed Soft Tissue Sarcoma That Can Be Removed by Surgery [Phase 2]